These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15832106)

  • 21. [A case of rheumatoid arthritis (RA) with drug-induced acute pancreatitis due to mizoribine].
    Yutsudo Y; Hasegawa Y; Takada T; Yamada H; Aoyama N; Morita S; Kasuga M
    Ryumachi; 1997 Aug; 37(4):564-7. PubMed ID: 9311282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does hypothyroidism potentialize muscular toxicity of fibrates?].
    Harlé JR; Toussirot E; Disdier P; Drancourt M; Weiller PJ
    Rev Med Interne; 1990; 11(4):336. PubMed ID: 2096444
    [No Abstract]   [Full Text] [Related]  

  • 23. Bezafibrate-induced rhabdomyolysis.
    Malnick SD; Badir A; Landau Z
    DICP; 1991; 25(7-8):869-70. PubMed ID: 1949949
    [No Abstract]   [Full Text] [Related]  

  • 24. Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.
    Wu J; Song Y; Li H; Chen J
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1169-74. PubMed ID: 19756555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rhabdomyolysis due to bezafibrate: a new case].
    Gas JM; Prados MC; Perdiguero M; Rivera F
    Med Clin (Barc); 1992 Feb; 98(4):156-7. PubMed ID: 1552772
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
    Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D
    Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Marked creatine-phosphokinase elevation in myopathy after treatment with bezafibrate].
    Slobodin G; Yeshurun D
    Harefuah; 2000 Sep; 139(5-6):193-5, 246. PubMed ID: 11062950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients.
    Unal A; Torun E; Sipahioglu MH; Tokgoz B; Kaya MG; Oymak O; Utas C
    Intern Med; 2008; 47(11):1017-9. PubMed ID: 18520113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyolysis induced by simvastatin-fluconazole combination.
    Hazin R; Abuzetun JY; Suker M; Porter J
    J Natl Med Assoc; 2008 Apr; 100(4):444-6. PubMed ID: 18481486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-lowering drugs: are adverse effects predictable and reversible?
    Muscari A; Puddu GM; Puddu P
    Cardiology; 2002; 97(3):115-21. PubMed ID: 12077562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.
    Maxa JL; Melton LB; Ogu CC; Sills MN; Limanni A
    Ann Pharmacother; 2002 May; 36(5):820-3. PubMed ID: 11978159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of systemic lupus erythematosus (SLE) successfully treated with mizoribine (Bredinin)].
    Iwasaki T; Hamano T; Aizawa K; Kobayashi K; Kakishita E
    Ryumachi; 1994 Oct; 34(5):885-9. PubMed ID: 7801201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
    Haubenstock A; Schmidt P; Zazgornik J; Balcke P; Kopsa H; Sertl K
    Dtsch Med Wochenschr; 1984 Jan; 109(4):157-8. PubMed ID: 6692783
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells.
    Maiguma T; Fujisaki K; Itoh Y; Makino K; Teshima D; Takahashi-Yanaga F; Sasaguri T; Oishi R
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):289-96. PubMed ID: 12644902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report.
    Kiskac M; Zorlu M; Cakirca M; Karatoprak C; Peru C; Erkoc R; Yavuz E
    Indian J Pharmacol; 2013; 45(3):305-6. PubMed ID: 23833382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenofibrate-induced rhabdomyolysis in a patient with stage 4 chronic renal failure due to diabetes mellitus.
    Soyoral YU; Canbaz ET; Erdur MF; Emre H; Begenik H; Erkoc R
    J Pak Med Assoc; 2012 Aug; 62(8):849-51. PubMed ID: 23862266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function changes in diabetic nephropathy induced by bezafibrate.
    Bruce R; Daniels A; Cundy T
    Nephron; 1996; 73(3):490. PubMed ID: 8832617
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rhabdomyolysis in patients with preexisting myopathy, treated with antilipemic agents].
    Franc S; Bruckert E; Giral P; Turpin G
    Presse Med; 1997 Dec; 26(38):1855-8. PubMed ID: 9569908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predominance of lactate dehydrogenase isoenzyme 1 in a patient with bezafibrate-induced rhabdomyolysis.
    Haubenstock A; Schröcksnadel W; Bauer K; Schmidt P; Gabl F
    Clin Chem; 1984 Sep; 30(9):1587-8. PubMed ID: 6467582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.